Investigator, Oncology Clinical Imaging - Stevenage, United Kingdom - GSK

GSK

Verified Company

Stevenage, United Kingdom

2 weeks ago

Posted by:

Tom O´Connor

beBee Recruiter

Description

Site Name:
UK - Hertfordshire - Stevenage, Cambridge 300 Technology Square, Cambridge Broadway, Rockville Biopharm, USA - Pennsylvania - Upper Providence, Waltham

Posted Date:
Jun 3 2024

397687 Investigator, Oncology Clinical Imaging
GSK's Precision Medicine group is seeking an Oncology Clinical Imaging expert to join our innovative team. Our mission is to evaluate, develop and implement imaging biomarkers in clinical drug development.

As part of our team, you will setup exploratory and registrational multicenter imaging studies using advanced radiological techniques and deliver robust data.

We create a place where people can grow, be their best, be safe, and feel welcome, valued and included.

We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.

We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.

Discover more about our company wide benefits and life at GSK on our webpage _Life at GSK | GSK_

In this role you will
-
Clinical Trials:Oversee and deliver imaging endpoints for Phase 1 to Phase 4 clinical trials, ensuring high-quality data and appropriate resource allocation.
-
Subject Matter Expertise:Serve as an in-house expert on imaging, particularly in later-phase clinical studies with common response assessment criteria.
-
Operational Excellence:Provide advice and recommendations on standardisation of imaging techniques to study teams and local Clin Ops colleagues, ensuring proper implementation and oversight of imaging in clinical trials.
-
Stakeholder Collaboration:Network within GSK's matrix environment to identify and meet stakeholder needs, progressing assets with cutting-edge imaging techniques.
-
Cross-Functional Collaboration:Work closely with study teams and advanced technology groups (AI/ML, Stats, Precision Medicine) to devise and implement imaging biomarkers in clinical study protocols.
-
External Relationships:Build and maintain relationships with key opinion leaders, imaging consultants, imaging CROs, and academic labs to support disease-specific imaging needs.
-
Global Network:Maintain a state-of-the-art knowledge of advances in imaging and represent GSK in external meetings and consortia.

_ Why you?_

Basic Qualifications & Skills:

We are looking for professionals with these required skills to achieve our goals:

Bachelor's degree in a biomedical or imaging-related field.
Experience in clinical imaging using multiple radiological imaging modalities (e.g. CT, PET, MRI).
Experience in clinical pharmacology or drug development.

Preferred Qualifications & Skills:

Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:

Medical, master's or PhD degree with imaging experience in drug development.
Understanding of cancer biology and staging.
Detailed biological knowledge of other, nononcology therapy areas
Handson experience with clinical imaging in a research or hospital environment.
Strong understanding of clinical trial design and statistics for endpoints.
Experience in clinical research working within an imaging CRO or within a pharmaceutical company.
Successful implementation of imaging strategies for biological targets or assets.
Experience in authoring scientific articles and clinical development documents.
Excellent communication, influencing skills, and the ability to work effectively in multidisciplinary teams.
Proactive, selfmotivated, and flexible working style.

Closing Date for Applications - June 24th, 2024 (COB)
Please take a copy of the Job Description, as this will not be available post closure of the advert.

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people over the next 10 years.

R&D is committed to discovering and delivering transformational vaccines and medicines to prevent and change the course of disease.

Science and technology are coming together in a way they never have before, and we have strong tech-enabled capabilities that allow us to build a deeper understanding of the patient, human biology and disease mechanisms, and transform medical discovery.

We are revolutionising the way we do R&D. We're uniting science, technology and talent to get ahead of disease together.

Find out more:
Our approach to R&D.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organisation where people can thrive.